Clinical Trials Browser

Phase 3 × OTHER_GOV × Stomach Neoplasms × Clear all

NCT06793917 2025-07-20

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT02112214 2024-12-27

HELPER

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT04214990 2024-12-27

EASTERN

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT01678027 2023-11-09

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

Phase 3 Active not recruiting

Gastrointestinal

Atrophy, Stomach Neoplasms

NCT04351867 2020-07-16

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Phase 3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT03264807 2020-03-03

Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

Phase 3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT03788226 2019-10-16

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Phase 3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02150447 2018-04-04

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

Phase 3 Terminated

Gastrointestinal

Hemorrhage, Stomach Neoplasms

NCT00546468 2012-05-24

NCC052

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

NCT00452751 2010-09-21

KLASS

Phase 3 Unknown

Gastrointestinal

Stomach Neoplasms